Hola,
Are you new here?

I have an account

¿Te ayudamos?

Ejemplos de búsqueda

Vídeos Explicativos

BCMolMed

financed

Closed

Molecular Medicine for Bladder Cancer

BCMolMed integrates complementary and multi-disciplinary expertise of two main (research-intensive SME-academia) and five associate partners with the objective to generate a state of the art training platform on application-orient... see more

30/09/2016

MOSAIQUES DIAGNOST...

668K€

Project Budget: 668K€

Project leader

MOSAIQUES DIAGNOSTICS GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 2 Participantes

Financing granted El organismo FP7 notifico la concesión del proyecto The day 2016-09-30 We do not have the information of the call

0% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

MOSAIQUES DIAGNOSTICS GMBH

0.00€ | Leader

BIOMEDICAL RESEARCH FOUNDATI...

N.D. | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project leader

MOSAIQUES DIAGNOSTICS GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 668K€

participation deadline Sin fecha límite de participación.

Project description BCMolMed integrates complementary and multi-disciplinary expertise of two main (research-intensive SME-academia) and five associate partners with the objective to generate a state of the art training platform on application-oriented biomarker research and systems biology. Special emphasis is placed on the efficient employment of proteomics and bioinformatics techniques to clinical research, and understanding clinical phenotypes in a spherical manner, in line to main EU research priorities. Research is applied to the identification of biomarkers and molecular determinants of bladder cancer recurrence and invasiveness, (with emphasis on extracellular matrix proteins), due to its clinical significance and availability of molecular data. The main industrial partner brings in commercial expertise and entrepreneurship, advanced proteomics technology and know-how on statistics, and a dynamic scientific commercial environment, highly complementing the academic partner bringing in knowledge on molecular biology and disease models disease, specific technologies and the academic ‘educational- focused mentality. The associate partners provide complementary knowledge on molecular biology, systems biology, and clinical expertise and resources. Besides providing a solid scientific foundation in the fields of proteomics, bladder cancer research and systems biology, the training program has been designed to equip the ESRs with efficient cross-discipline communication skills capable to reach multiple target groups. A structured curriculum is proposed consisting of individual research projects, secondments between partners, and various training modules (courses, workshops, webinars). This integrative approach can be substantially beneficial and is expected to generate effective researchers and entrepreneurs in the fields of biomarker and drug target while providing valuable insight in bladder cancer molecular pathology and validated biomarkers.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers